Search results for " GAS"

showing 10 items of 4643 documents

Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis

2018

Hepatic vitamin D receptor (VDR) expression is increased in patients with nonalcoholic fatty liver (NAFL) and is required for liver steatosis in an NAFL mouse model. However, how hepatocyte VDR is involved in setting up steatosis remains unclear. The authors transduced human hepatocyte-derived cells with an adenoviral vector encoding human VDR and found that angiopoietin-like protein 8 (ANGPTL8) expression was increased upon VDR activation by vitamin D or lithocholic acid. The mRNA levels of hepatic VDR- and vitamin D-related genes [cytochrome P450 (CYP) 2R1, CYP27A1, and CYP3A4] were higher in NAFL patients compared with normal liver subjects. Noteworthy, hepatic ANGPTL8 mRNA and protein l…

AdultMale0301 basic medicinemedicine.medical_specialtyLithocholic acidPeptide HormonesFatty Acids NonesterifiedCalcitriol receptorPathology and Forensic Medicine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAngiopoietin-Like Protein 8Non-alcoholic Fatty Liver DiseaseInternal medicineCYP27A1medicineHumansInsulinCells CulturedTriglyceridesGene knockdownCYP3A4Fatty liverMiddle Agedmedicine.diseaseAngiopoietin-like Proteins030104 developmental biologymedicine.anatomical_structureEndocrinologyGene Expression RegulationchemistryCase-Control StudiesHepatocyteHepatocytesReceptors CalcitriolFemale030211 gastroenterology & hepatologySteatosisThe American Journal of Pathology
researchProduct

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals

2018

The emergence of resistance-associated substitutions (RASs) can compromise the high efficacy of direct-acting antivirals (DAAs). Little is known about RASs selection at very early time points during DAA treatment. Therefore, we analyzed the potential emergence of RASs immediately after therapy initiation. Samples of 71 patients treated with different DAAs were collected at baseline, during therapy (hours 4 and 8; days 1-7; weeks 2-4) or until target not detected. HCV-RNA levels were determined by qPCR, and RASs were detected by deep sequencing. Sixty-three (89%) patients achieved a sustained virological response (SVR), 7 (10%) relapsed, and 1 (1%) experienced a breakthrough. Almost all non-…

AdultMale0301 basic medicinemedicine.medical_specialtySustained Virologic ResponseHepatitis C virusHepacivirusViral quasispeciesReal-Time Polymerase Chain ReactionDIRECT ACTING ANTIVIRALSmedicine.disease_causeAntiviral AgentsGastroenterologyDeep sequencingVirological response03 medical and health sciences0302 clinical medicineRecurrenceGenetic EvolutionVirologyInternal medicineDrug Resistance ViralHumansMedicineProspective StudiesSelection GeneticAgedAged 80 and overHepatologybusiness.industryAntiviral therapyvirus diseasesHepatitis C ChronicMiddle AgedViral Loaddigestive system diseases030104 developmental biologyInfectious DiseasesAmino Acid SubstitutionRNA ViralFemale030211 gastroenterology & hepatologySensitivity limitbusinessJournal of Viral Hepatitis
researchProduct

Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study

2016

Objective The biological heterogeneity of hepatocellular carcinoma (HCC) makes prognosis difficult. We translate the results of a genome-wide high-throughput analysis into a tool that accurately predicts at presentation tumour growth and survival of patients with HCC.Design Ultrasound surveillance identified HCC in 78 (training set) and 54 (validation set) consecutive patients with cirrhosis. Patients underwent two CT scans 6 weeks apart (no treatment in-between) to determine tumour volumes (V-0 and V-1) and calculate HCC doubling time. Baseline-paired HCC and surrounding tissue biopsies for microarray study (Agilent Whole Human Genome Oligo Microarrays) were also obtained. Predictors of su…

AdultMale0301 basic medicinemedicine.medical_specialtyTime FactorsCarcinoma HepatocellularTime FactorMicroarrayHepatocellular carcinomamolecular carcinogenesisGastroenterologyliver imagingHEPATOCELLULAR CARCINOMA; LIVER IMAGING; MOLECULAR CARCINOGENESIS; MOLECULAR ONCOLOGY; Adult; Aged; Aged 80 and over; Carcinoma Hepatocellular; Disease Progression; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization Pathologic; Prospective Studies; Survival Rate; Time Factors; Tumor Burden; Medicine (all); Gastroenterology03 medical and health sciencesmolecular oncology0302 clinical medicineHepatocellular carcinoma liver imaging molecular carcinogenesis molecular oncologyInternal medicinemedicineCarcinomaHumansDoubling timeProspective StudiesProspective cohort studySurvival rateAgedAged 80 and overNeovascularization Pathologicbusiness.industryProportional hazards modelLiver NeoplasmsGastroenterologyMiddle Agedmedicine.diseaseTumor BurdenSurvival RateProspective Studie030104 developmental biologyQuartileLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaDisease ProgressionFemalebusinessHumanGut
researchProduct

Non-alcoholic fatty liver disease is associated with higher metabolic expenditure in overweight and obese subjects: A case-control study

2019

Non-alcoholic fatty liver disease (NAFLD) is a common condition in Western countries. However, their metabolic characteristics are poorly known even though they could be important. Therefore, the objective of this study was to measure resting metabolic parameters in overweight/obese adults with hepatic steatosis compared to controls, matched for age, sex, and obesity level. Hepatic steatosis was diagnosed with liver ultrasound. Energy metabolism was measured with indirect calorimetry: energy expenditure (REE), predicted REE, the ratio between REE and the predicted REE, and the respiratory quotient (RQ) were reported. We measured some anthropometric, body composition, and bio-humoral paramet…

AdultMale0301 basic medicinemedicine.medical_specialtyobesitylcsh:TX341-641OverweightGastroenterologyArticle03 medical and health sciences0302 clinical medicineLiver -- Diseases -- Case studiesNon-alcoholic Fatty Liver DiseaseInternal medicineNAFLDmedicineNon-alcoholic fatty liver disease -- Case studiesOverweight persons -- Case studiesHumansObesity -- Complications -- Case studiesNutrition and Dieteticsbusiness.industryFatty liverCase-control studyCalorimetry IndirectEnergy metabolismMiddle AgedOverweightAnthropometrymedicine.diseaseObesityRespiratory quotient030104 developmental biologyCase-Control StudiesCohortBody CompositionFemale030211 gastroenterology & hepatologySteatosismedicine.symptomEnergy Metabolismbusinesslcsh:Nutrition. Foods and food supplymetabolismFood Science
researchProduct

High-frequency oscillatory ventilation in adults with traumatic brain injury and acute respiratory distress syndrome

2005

This study observed adverse events of rescue treatment with high-frequency oscillatory ventilation (HFOV) in head-injured patients with acute respiratory distress syndrome (ARDS).Data of five male patients with ARDS and traumatic brain injury, median age 28 years, who failed to respond to conventional pressure-controlled ventilation (PCV) were analyzed retrospectively during HFOV. Adjusted mean airway pressure at initiation of HFOV was set to 5 cm H2O above the last measured mean airway pressure during PCV. Frequency of pulmonary air leak, mucus obstruction, tracheal injury, and need of HFOV termination due to increased intracranial pressure, decreased cerebral perfusion pressure, or deteri…

AdultMaleARDSTime FactorsAdolescentIntracranial PressureTraumatic brain injurymedicine.medical_treatmentHigh-Frequency VentilationBlood PressureMean airway pressuremedicineHumansCerebral perfusion pressureMonitoring PhysiologicRetrospective StudiesIntracranial pressureRespiratory Distress SyndromeRespiratory distressbusiness.industryHigh-frequency ventilationGeneral MedicineCarbon DioxideMiddle Agedrespiratory systemmedicine.diseaseAnesthesiology and Pain MedicineBrain InjuriesAnesthesiaBreathingBlood Gas Analysisbusiness
researchProduct

The latent structure of the functional dyspepsia symptom complex: A taxometric analysis

2016

OBJECTIVES: Rome III introduced a subdivision of functional dyspepsia (FD) into postprandial distress syndrome and epigastric pain syndrome, characterized by early satiation/postprandial fullness, and epigastric pain/burning, respectively. However, evidence on their degree of overlap is mixed. We aimed to investigate the latent structure of FD to test whether distinguishable symptom-based subgroups exist. METHODS: Consecutive tertiary care Rome II FD patients completed the dyspepsia symptom severity scale. Confirmatory factor analysis (CFA) was used to compare the fit of a single factor model, a correlated three-factor model based on Rome III subgroups and a bifactor model consisting of a g…

AdultMaleAbdominal painAdolescentPhysiologyEpigastric painYoung Adult03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesmedicineHumansDyspepsiaLatent structureAgedAged 80 and overTertiary HealthcareEndocrine and Autonomic Systemsbusiness.industrySingle factorGastroenterologyNauseaMiddle AgedClassificationPostprandial Periodmedicine.diseaseRome iiiConfirmatory factor analysisAbdominal PainDistress030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologymedicine.symptombusinessSomatizationClinical psychology
researchProduct

Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: A multi-cen…

2015

Abstract Objectives Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis that has been reported worldwide for the last two decades. The aim of this study is to analyse the clinical profile of patients from Spain with AIP, as well as treatments, relapses and long-term outcomes. Methods Data from 59 patients with suspected AIP that had been diagnosed in 15 institutions are retrospectively analysed. Subjects are classified according to the International Consensus Diagnostic Criteria (ICDC). Patients with type 1 AIP (AIP1) and type 2 AIP (AIP2) are compared. Kaplan–Meier methodology is used to estimate the overall survival without relapses. Results Fifty-two patients met ICDC, 45 pat…

AdultMaleAbdominal painmedicine.medical_specialtyPathologyConsensusEndocrinology Diabetes and MetabolismKaplan-Meier EstimateDisease-Free SurvivalAutoimmune Diseases03 medical and health sciences0302 clinical medicineInternal medicinePancreatitis ChronicmedicineCombined Modality TherapyHumansPancreatitis chronicMulti centreAutoimmune pancreatitisAgedRetrospective StudiesHepatologybusiness.industryGastroenterologyRetrospective cohort studyMiddle Agedmedicine.diseaseCombined Modality TherapyTreatment OutcomeDiagnosis treatmentSpain030220 oncology & carcinogenesisPractice Guidelines as TopicPancreatitis030211 gastroenterology & hepatologyFemalemedicine.symptombusinessFollow-Up StudiesPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
researchProduct

Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity

2014

Summary Common autoimmune disorders tend to co-exist in the same subjects and cluster in families. The objective of this study was to determine the prevalence of autoimmune co-morbidity in patients with autoimmune thyroid disease (AITD) with and without thyroid-associated orbitopathy (TAO). This was a cross-sectional study conducted at an academic tertiary referral centre. Of 1310 patients with AITD [n = 777 or 59% with Graves' disease (GD) and n = 533, 41% with Hashimoto's thyroiditis (HT)] followed at a specialized joint thyroid–eye out-patient clinic, 176 (13·4%) had an adult type of the autoimmune polyglandular syndrome, 129 (9·8%) type 1 diabetes, 111 (8·5%) coeliac disease, 60 (4·6%) …

AdultMaleAdolescentAutoimmune GastritisImmunologyThyroid GlandAutoimmunityVitiligomedicine.disease_causeCoeliac diseaseThyroiditisAutoimmune DiseasesAutoimmunityYoung AdultOrbital DiseasesPrevalencemedicineHumansImmunology and AllergyChildAgedRetrospective StudiesAged 80 and overType 1 diabetesbusiness.industryOriginal ArticlesMiddle AgedAlopecia areatamedicine.diseaseThyroid DiseasesGastrointestinal TractGraves OphthalmopathyCross-Sectional StudiesChild PreschoolRheumatoid arthritisImmunologyFemalebusinessClinical and Experimental Immunology
researchProduct

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C.

2012

Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been recognized. The aim of this study was to identify factors predictive of sustained virological response (SVR) to PEG IFN/Ribavirin antiviral therapy in relation to gender and reproductive status of female patients involved. Seven hundred and forty-six treatment-naïve patients (431 men, 315 women) treated with Peg-IFNα-2a (180 μg/week) or Peg-IFNα-2b (1.5 μg/kg/week) plus ribavirin (800–1400 mg/day) for 24 or 48 weeks were studied between 2006 and 2010. Differences in SVR rate, overall and by gender were assessed after adjustment and propensity score matching. SVR was obtained in 44.2% of Peg-…

AdultMaleAdolescentInterferon alpha-2Antiviral AgentsPolyethylene GlycolsYoung AdultSex FactorsRibaviringenderHumansAgedSettore MED/12 - GastroenterologiaPeg IFNAge FactorsInterferon-alphaHepatitis C ChronicMiddle Agedcentral fat distribution cytokines metabolic syndrome pharmacokinetics sustained virological responseRecombinant ProteinsTreatment OutcomeDrug Therapy CombinationFemaleEpatite HCV; Peg IFN; genderMenopauseSettore SECS-S/01 - StatisticaEpatite HCVJournal of viral hepatitis
researchProduct

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic…

1996

Abstract Antibodies directed to the HBs antigen indicate viral clearance and the development of life-long immunity in patients that recovered from HBV infection. In HBs antigen vaccine recipients anti-HBs antibodies provide protective immunity. However, little is known about the regulation of this HBs-specific antibody response. The existence of anti-HBs-secreting B cells was demonstrated using the highly sensitive ELISPOT technique compared with conventional ELISA in serum and cell culture supernatants. In the peripheral blood of patients with acute self-limited hepatitis B, HBs-specific B cells were demonstrated with a high frequency despite undetectable anti-HBs serum antibodies. HBV-imm…

AdultMaleAdolescentT-LymphocytesImmunologymedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemNeutralization TestsImmunityHumansImmunology and AllergyMedicineHepatitis B VaccinesHepatitis B AntibodiesRapid PublicationsB cellAgedHepatitis Chronic030304 developmental biologyHepatitis B virusB-LymphocytesImmunity Cellular0303 health sciencesHepatitis B Surface Antigensbiologybusiness.industryELISPOTvirus diseasesMiddle AgedHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationVirologydigestive system diseases3. Good healthmedicine.anatomical_structureHepadnaviridaeAcute DiseaseImmunologybiology.proteinFemale030211 gastroenterology & hepatologyAntibodybusinessClinical and Experimental Immunology
researchProduct